1 report

  • May 15, 2017: Selecta Biosciences Announces New Preclinical Gene Therapy Data at the Annual Meeting of the American Society of Gene & Cell Therapy
  • 05/01/2017: Selecta Biosciences Announces Presentations at the 20th Annual Meeting of the American Society of Gene & Cell Therapy

We also obtained a key license for our MMA gene therapy program, and we began dosing patients in a Phase ## trial of our nicotine vaccine candidate for smoking cessation and relapse prevention.

  • Gene Therapy
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Selecta Biosciences, Inc.